The End of the Transactional Grant: UKRI's New Strategy Explained
UKRI published two documents this month, a five-year strategy and a delivery plan for the year ahead, and most founders will scroll straight past them. It's a fair response. They're somehow both dense and wishy-washy at the same time. But ignoring it would be a mistake. Buried in the civil-service register of “priority programmes” and “outcome-focused investment” is a genuinely different theory of what UKRI is for. Luckily, I'm a glutton for punishment and have pored over it all to pick out the key pieces you need to know and why.
UKRI is no longer positioning itself as a body that hands out grants and trusts that impact will blossom naturally. Where it once watered the seeds and watched for plants to grow, it now positions itself as an active gardener: fertiliser in one hand, secateurs in the other.
This is a significant refresh, with the funding body taking on the mantle of portfolio manager; tracking promising companies, timing its interventions, and measuring its own success by how much private capital flows into the furrows it ploughs. This shift is likely to change what winning applications looks like, and it will reward founders who engage with the strategy closely a great deal more than those who don't.
What has UKRI actually changed?
For my money (and more importantly for UKRI's), there are a barbershop's quartet of shifts that matter most in this.
Deep tech, defined. We've seen the writing on the wall for a good 18 months. This is UKRI signing off on no longer funding ‘innovation’ in a general sense. Its delivery plan sets out three clear criteria for the types of businesses it wants to back: potential (a novel idea, a strong team, credible technology, a clear market, and the resources to move); progress (evidence of momentum); and genuine need (a gap the market alone will not close).
That all sits alongside what they're calling a new “robust business assessment framework” scoring team capability, the breakthrough nature of the technology, and alignment with the government's Industrial Strategy sectors. Sector-agnostic innovation funding that allows all comers to have a crack is being quietly deprioritised in favour of a much more targeted set of filters.
Velocity: portfolio thinking, made explicit. This is the most VC-like commitment in the whole update. UKRI says it will track the UK's most promising deep tech companies as they scale, stepping in when its support can make the greatest difference, and stepping back deliberately as private investment takes over. UKRI isn't in this with you for the full journey, I think. More so than ever before, you have to be planning for a diverse capital stack to progress from prototyping through to revenue.
UKRI has also set itself an ambitious, but calculated target. Namely that over 55% of businesses in its portfolio should have taken on private equity or venture capital investment within five years of obtaining R&D grant funding. That more closely resembles how a fund manages a book of positions than it does a traditional public-money-backed grant funder.
Desk rejection and AI-assisted reviewer matching. This one is actually kind of easy to gloss over because it sits in the powder-dry organisational-reform section, but it is genuinely material and worth being clued into. UKRI is scaling up trials of utilising AI in desk rejection to screen some applications out before they ever reach a human reviewer. In addition, they want to streamline the process of distributing assessor reviews, and are already using automated subject classification to generate shortlists of which expert reviewers see which applications. The reason to give a hoot is that your framing on the initial summary and scope section of a grant proposal now has a lot more riding on it than it used to back when sifted-out applications normally constituted a single-digit percentage of overall applicants. Put simply, a growing share of the process is deciding, before a human reads closely, whether your application is worth a close read at all.
IP anchoring as a hard condition of funding. Easily missed alongside the more headline-grabbing changes, but genuinely material: UKRI is refreshing its intellectual property policies, with new IP grant terms landing by November 2026, explicitly designed to “better anchor IP exploitation and economic value from public investment in R&I in the UK.” The strategy is unambiguous that the goal is to maximise the economic, social, and cultural value of UK-generated IP, and to reduce barriers to it being commercialised effectively within the UK rather than licensed away. What this means in the nitty and gritty is that founders receiving UKRI funding should expect the terms of that funding to increasingly reflect where and how the resulting IP is exploited, not just whether the research gets done. For teams already thinking about international licensing deals or overseas spinout structures, this is worth reading closely before your next application. It is a shift in what public money is buying, not just regarding the science, but the economic return staying onshore.
The new plan reads less like a grant circular and more like an investment memo: watch, wait, step in, step back.
What this means for founders
- Framing matters more than it used to. If a growing proportion of applications face desk rejection or automated reviewer routing, the opening of your application really does have to be the whole pitch in miniature. If potential, progress, and need aren't communicated conclusively on your first page, a strong middle section may well never get read at all.
- Investment-readiness is now part of the grant, not a subsequent step achieved by dint of getting a grant. UKRI is explicit that it briefs investors on its own pipeline, and it wants applicants to set out expectations for private investment, including what's already pledged and what's anticipated, from the outset. An application that can't credibly connect to a follow-on private capital story has at least one hand tied behind its back, regardless of the quality of the underlying science.
- The gap between strong and weak applications will almost certainly widen. Desk rejection punishes the eligible-but-unremarkable application faster than the old system did. To be clear, this is a good thing. Applications with a clean read on potential, progress, need, and sector alignment will win more decisively. There is less room in the middle to coast on eligibility alone and less chance that public funding will be misallocated to supporting well-argued but poorly planned projects.
Whether old hat or new blood, it's going to be the founders and innovators who engage with this strategy properly and adjust how they frame their applications who will benefit from the version of UKRI that seems to be arriving. Everyone else will keep applying to the one that's already a thing of the past.
Ailsa matches real technical readiness to the funders built to support it, especially with a revamped UKRI behaving like a portfolio investor. Learn more at ailsa.io.
More insights.

AI didn’t change tech grants. It changed who wins them.
A grounded look at where AI is actually helping founders win tech grant funding, and how relying solely on it is quietly costing them money.
Read insight
Biotech startup funding needs a flight plan
Biotech startups that raise more funding aren't the ones that move fastest, they're the ones who planned their route furthest in advance.
Read insight
One Word That Quietly Torpedoes Funding Applications
Ask ten funders what a "prototype" is and you’re liable to get ten different answers back. That fragmentation is costing founders real opportunities.
Read insight